PX3AXS
Roderick Cavin is an experienced executive with a robust background in business development and leadership across various healthcare and pharmaceutical organizations. Currently serving as Executive Director at PX3AXS and as a Board Member for Sheridan Capital Partners, Roderick also leads Blue Anchors as President, focusing on scaling mid-market innovators. Previously, Roderick held the position of Principal at Zensights LLC, enhancing partnerships within BioPharma, and was General Manager at EVERSANA, following the successful sale of Health Strategies Group, where Roderick served as President/CEO. With a solid foundation in clinical services and strategic growth, Roderick also possesses extensive educational credentials, including an MBA from the Gies College of Business and a certificate in Digital Business Strategy from the MIT Sloan School of Management.
This person is not in any teams
PX3AXS
PX3 AXS is a life sciences company dedicated to partnering with leading biopharmaceutical organizations throughout the product lifecycle by connecting the dots between providers, payers, and patients to transform access to treatments for life-threatening diseases. PX3 AXS is different by design with the unique ability to translate complex science to product adoption by developing tailored strategies and solutions, redefining the end-to-end patient experience. Each patient's journey is unique. Every product requires a custom roadmap. Let’s connect the dots together.